Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L. M. Terekhina"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 11-12, Pp 16-21 (2020)
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacter
Externí odkaz:
https://doaj.org/article/7b43c320b9d0440fa2edfc381389b758
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 11-12, Pp 23-25 (2020)
Resistance of Mycobacterium tuberculosis isolated from new cases registered during a period from 2007 to 2012 was estimated. High rate of the M.tuberculosis multiple drug resistance increase was observed: from 28% in 2007 to 64% in 2012. Low efficacy
Externí odkaz:
https://doaj.org/article/46146ae3fc5742d09a6576edf082cacf
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 58(11-12)
Resistance of Mycobacterium tuberculosis isolated from new cases registered during a period from 2007 to 2012 was estimated. High rate of the M.tuberculosis multiple drug resistance increase was observed: from 28% in 2007 to 64% in 2012. Low efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29bcfd51b448323e9842a16d38cfbbec
https://pubmed.ncbi.nlm.nih.gov/24734425
https://pubmed.ncbi.nlm.nih.gov/24734425
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 57(11-12)
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b3b89313ef8e443e93c33bd5d31fecd
https://pubmed.ncbi.nlm.nih.gov/23700932
https://pubmed.ncbi.nlm.nih.gov/23700932